168 related articles for article (PubMed ID: 19433357)
1. Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors.
Shin Y; Chen W; Habel J; Duckett D; Ling YY; Koenig M; He Y; Vojkovsky T; LoGrasso P; Kamenecka TM
Bioorg Med Chem Lett; 2009 Jun; 19(12):3344-7. PubMed ID: 19433357
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and SAR of 2-phenoxypyridines as novel c-Jun N-terminal kinase inhibitors.
Song X; Chen W; Lin L; Ruiz CH; Cameron MD; Duckett DR; Kamenecka TM
Bioorg Med Chem Lett; 2011 Dec; 21(23):7072-5. PubMed ID: 22004719
[TBL] [Abstract][Full Text] [Related]
3. 3,5-Disubstituted quinolines as novel c-Jun N-terminal kinase inhibitors.
Jiang R; Duckett D; Chen W; Habel J; Ling YY; LoGrasso P; Kamenecka TM
Bioorg Med Chem Lett; 2007 Nov; 17(22):6378-82. PubMed ID: 17911023
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) inhibitors.
He Y; Kamenecka TM; Shin Y; Song X; Jiang R; Noel R; Duckett D; Chen W; Ling YY; Cameron MD; Lin L; Khan S; Koenig M; LoGrasso PV
Bioorg Med Chem Lett; 2011 Mar; 21(6):1719-23. PubMed ID: 21316221
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and SAR of novel isoxazoles as potent c-jun N-terminal kinase (JNK) inhibitors.
He Y; Duckett D; Chen W; Ling YY; Cameron MD; Lin L; Ruiz CH; Lograsso PV; Kamenecka TM; Koenig M
Bioorg Med Chem Lett; 2014 Jan; 24(1):161-4. PubMed ID: 24332487
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR of 4-(pyrazol-3-yl)-pyridines as novel c-jun N-terminal kinase inhibitors.
Noël R; Shin Y; Song X; He Y; Koenig M; Chen W; Ling YY; Lin L; Ruiz CH; LoGrasso P; Cameron MD; Duckett DR; Kamenecka TM
Bioorg Med Chem Lett; 2011 May; 21(9):2732-5. PubMed ID: 21185177
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitors.
Zhao H; Serby MD; Xin Z; Szczepankiewicz BG; Liu M; Kosogof C; Liu B; Nelson LT; Johnson EF; Wang S; Pederson T; Gum RJ; Clampit JE; Haasch DL; Abad-Zapatero C; Fry EH; Rondinone C; Trevillyan JM; Sham HL; Liu G
J Med Chem; 2006 Jul; 49(15):4455-8. PubMed ID: 16854050
[TBL] [Abstract][Full Text] [Related]
8. Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole lead.
Palmer WS; Alam M; Arzeno HB; Chang KC; Dunn JP; Goldstein DM; Gong L; Goyal B; Hermann JC; Hogg JH; Hsieh G; Jahangir A; Janson C; Jin S; Ursula Kammlott R; Kuglstatter A; Lukacs C; Michoud C; Niu L; Reuter DC; Shao A; Silva T; Trejo-Martin TA; Stein K; Tan YC; Tivitmahaisoon P; Tran P; Wagner P; Weller P; Wu SY
Bioorg Med Chem Lett; 2013 Mar; 23(5):1486-92. PubMed ID: 23352510
[TBL] [Abstract][Full Text] [Related]
9. Pyrazole derivatives as potent inhibitors of c-Jun N-terminal kinase: synthesis and SAR studies.
Doma A; Kulkarni R; Palakodety R; Sastry GN; Sridhara J; Garlapati A
Bioorg Med Chem; 2014 Nov; 22(21):6209-19. PubMed ID: 25261929
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.
Humphries PS; Lafontaine JA; Agree CS; Alexander D; Chen P; Do QQ; Li LY; Lunney EA; Rajapakse RJ; Siegel K; Timofeevski SL; Wang T; Wilhite DM
Bioorg Med Chem Lett; 2009 Apr; 19(8):2099-102. PubMed ID: 19327989
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of 1-aryl-5-anilinoindazoles as c-Jun N-terminal kinase inhibitors.
Jiang R; Frackowiak B; Shin Y; Song X; Chen W; Lin L; Cameron MD; Duckett DR; Kamenecka TM
Bioorg Med Chem Lett; 2013 May; 23(9):2683-7. PubMed ID: 23518277
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors.
De SK; Chen V; Stebbins JL; Chen LH; Cellitti JF; Machleidt T; Barile E; Riel-Mehan M; Dahl R; Yang L; Emdadi A; Murphy R; Pellecchia M
Bioorg Med Chem; 2010 Jan; 18(2):590-6. PubMed ID: 20045647
[TBL] [Abstract][Full Text] [Related]
13. Aminopyridine carboxamides as c-Jun N-terminal kinase inhibitors: targeting the gatekeeper residue and beyond.
Liu G; Zhao H; Liu B; Xin Z; Liu M; Kosogof C; Szczepankiewicz BG; Wang S; Clampit JE; Gum RJ; Haasch DL; Trevillyan JM; Sham HL
Bioorg Med Chem Lett; 2006 Nov; 16(22):5723-30. PubMed ID: 16971120
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and structure-activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase.
De SK; Barile E; Chen V; Stebbins JL; Cellitti JF; Machleidt T; Carlson CB; Yang L; Dahl R; Pellecchia M
Bioorg Med Chem; 2011 Apr; 19(8):2582-8. PubMed ID: 21458276
[TBL] [Abstract][Full Text] [Related]
15. Biphenyl amide p38 kinase inhibitors 2: Optimisation and SAR.
Angell RM; Angell TD; Bamborough P; Brown D; Brown M; Buckton JB; Cockerill SG; Edwards CD; Jones KL; Longstaff T; Smee PA; Smith KJ; Somers DO; Walker AL; Willson M
Bioorg Med Chem Lett; 2008 Jan; 18(1):324-8. PubMed ID: 17981461
[TBL] [Abstract][Full Text] [Related]
16. N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.
Angell RM; Atkinson FL; Brown MJ; Chuang TT; Christopher JA; Cichy-Knight M; Dunn AK; Hightower KE; Malkakorpi S; Musgrave JR; Neu M; Rowland P; Shea RL; Smith JL; Somers DO; Thomas SA; Thompson G; Wang R
Bioorg Med Chem Lett; 2007 Mar; 17(5):1296-301. PubMed ID: 17194588
[TBL] [Abstract][Full Text] [Related]
17. Structure-driven HtL: design and synthesis of novel aminoindazole inhibitors of c-Jun N-terminal kinase activity.
Stocks MJ; Barber S; Ford R; Leroux F; St-Gallay S; Teague S; Xue Y
Bioorg Med Chem Lett; 2005 Jul; 15(14):3459-62. PubMed ID: 15950471
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.
Schepetkin IA; Khlebnikov AI; Potapov AS; Kovrizhina AR; Matveevskaya VV; Belyanin ML; Atochin DN; Zanoza SO; Gaidarzhy NM; Lyakhov SA; Kirpotina LN; Quinn MT
Eur J Med Chem; 2019 Jan; 161():179-191. PubMed ID: 30347329
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-jun-N-terminal kinase (JNK) inhibitors.
Kamenecka T; Jiang R; Song X; Duckett D; Chen W; Ling YY; Habel J; Laughlin JD; Chambers J; Figuera-Losada M; Cameron MD; Lin L; Ruiz CH; LoGrasso PV
J Med Chem; 2010 Jan; 53(1):419-31. PubMed ID: 19947601
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and SAR of 1,9-dihydro-9-hydroxypyrazolo[3,4-b]quinolin-4-ones as novel, selective c-Jun N-terminal kinase inhibitors.
Liu M; Xin Z; Clampit JE; Wang S; Gum RJ; Haasch DL; Trevillyan JM; Abad-Zapatero C; Fry EH; Sham HL; Liu G
Bioorg Med Chem Lett; 2006 May; 16(10):2590-4. PubMed ID: 16527482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
